GoldenGolden
Advanced Search
11.2 Capital

11.2 Capital

A venture capital and private equity firm focused on emerging technologies in artificial intelligence, cybersecurity, robotics, quantum, new space, computational therapeutics and synthetic biology.

11.2 Capital is a venture capital and private equity firm focused on emerging technologies in artificial intelligence, cybersecurity, robotics, quantum, new space, computational therapeutics and synthetic biology that is headquartered in San Francisco, California and was founded in 2014 by Shelley Zhuang. The firm specializes in offering its early stage companies several services such as technical recruiting, partnerships, customer introductions, and follow-on financing.

Notable investments made by 11.2 Capital include: TigerGraph, WhiteOps, Avaamo, Ginkgo Bioworks, Forter, Aunransa, Bay Labs, Cruise, Vertical, Notable Labs, Savioke, Molecular Assemblies, Kindred, Deep Genomics, and Lucira Health.

Timeline

2014
11.2 Capital was founded by Shelley Zhuang.

People

Name
Role
LinkedIn

David Dorsey

Principal -- Data architectures, AI/ML, dev tools

Jacob Smith

Principal -- Healthcare and Bio

Pramod Gosavi

Principal -- Enterprise infrastructure software and security

Shelley Zhuang

Founder and Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.